Announcement on Change of Sponsor Representative
Filed with SSE · · 2 pages · Chinese
Nanjing Vazyme Biotech Co., Ltd. on 6ix
Earlier from Nanjing Vazyme Biotech
- Announcement on Plan for Repurchasing Shares through Call Auction
- Indicative Announcement on the Proposal of Chairman, General Manager and Actual Controller to Repurchase Shares
- Announcement on Voluntary Disclosure of Obtaining China Patent Excellent Award
- Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement and Proposed Establishment of Joint Venture
- Announcement on Implementation of Dividend Distribution for 2024
Later from Nanjing Vazyme Biotech
- 2025 Semi-annual Report
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Subsidiary’s Product
- Announcement on By-election of Non-independent Director
Follow Nanjing Vazyme Biotech into a list and get an email when it puts out news.
Follow Nanjing Vazyme Biotech